Skip to content

Real-World Evaluation of the Effect of Jublia on Nail Polish

Real-World Evaluation of the Effect of Jublia on Nail Polish

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03022916
Enrollment
5
Registered
2017-01-18
Start date
2015-09-30
Completion date
2017-12-31
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Evaluation of Jublia on Nail Polish With Healthy Toenails

Keywords

toenail polish, jublia

Brief summary

A recent publication using cadaver nails suggests that Jublia application has a negative effect on nail polish texture.

Detailed description

It is believed that investigating the affect of Jublia is an important question with regards to how it affects how various nail polished and top coats will be used.

Interventions

DRUGNail Polish + Efinaconazole Solution

Application of Jublia to the nail of one big toe on top of the nail polish

Application of nail polish only to both big toe nails

DRUGBase Coat + Nail Polish + Top Coat + Efinaconazole Solution

Application of Jublia to the nail of one big toe on top of the nail polish with layers of top coat and base coat

DRUGNail Polish + Top Coat + Efinaconazole Solution

Application of Jublia to the nail of one big toe on top of the nail polish with layer of top coat

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Exhibit distal lateral subungual onychomycosis (DLSO) * Has the informed consent been signed and patient's questions answered. * Age ≥ 18 * Patient willing and able to participate for the full duration of the study * No onychomycosis * Greater than 4 weeks from prior major surgery for any indication * Willing to abstain from: * The application of other topical medications or cosmetic products to the toenail * Professional pedicures for the duration of the study. * Females of childbearing potential must: * Have been using adequate contraception (abstinence, IUD, birth control pills or spermicidal gel with diaphragm or condom) since their last menses * Agree to continue using adequate means of contraception (abstinence, IUD, birth control pills or spermicidal gel with diaphragm or condom) for the duration of study participation * Females are not considered to be of childbearing potential if they are at least 1 year postmenopausal or have had a tubal ligation, bilateral oophorectomy or hysterectomy.

Exclusion criteria

* Active onychomycosis of the toenails or fingernails * Any of the following in the 4 weeks (or as indicated) prior to randomization: * Major surgery for any indication * Any personal history of: * Invasive cancer diagnosed or treated within the past 5 years. Participants who have been in remission for 5 years or more and have not required treatment in the past 5 years may be eligible if the principal investigator believes there is little to no risk of recurrence. * Concurrent use of the following medications or treatments * Other topical antifungals for any concomitant infection * Females who are pregnant or lactating. Should a woman become pregnant or suspect she is pregnant while she is participating in this study she should notify the study physician immediately. * Uncontrolled concurrent illness including ongoing or active infection, psychiatric illness or social situations that would limit compliance with study requirements or other underlying serious medical condition which, in the investigator's opinion, might preclude study participation.

Design outcomes

Primary

MeasureTime frameDescription
Observe Stability of Nail Polish as Evidenced by Serial Photography With Efinaconazole Application in Terms of DaysBaseline to 14 daysObservation: Serial photographs were combined with patient reported outcomes to assess the stability of self-applied toenail polish when efinaconazole was applied topically to the nail. (Expected stability of polish less than 14 days with application of Jublia as compared to nails without Jublia application)

Countries

United States

Participant flow

Pre-assignment details

Each patient served as their own control. One big toenail received nail polish only and the other big toenail was treated with nail polish and efinaconazole solution.

Participants by arm

ArmCount
Jublia
Both big toes will receive application of toenail polish. One big toe will not use Jublia. Jublia: Application of Jublia to one big toenail Nail polish: Application of nail polish to both big toe nails Subjects had to be healthy and have a big toenail
5
Total5

Baseline characteristics

CharacteristicJublia
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
5 Participants
Race (NIH/OMB)
White
0 Participants
Region of Enrollment
United States
5 Participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 5
other
Total, other adverse events
0 / 5
serious
Total, serious adverse events
0 / 5

Outcome results

Primary

Observe Stability of Nail Polish as Evidenced by Serial Photography With Efinaconazole Application in Terms of Days

Observation: Serial photographs were combined with patient reported outcomes to assess the stability of self-applied toenail polish when efinaconazole was applied topically to the nail. (Expected stability of polish less than 14 days with application of Jublia as compared to nails without Jublia application)

Time frame: Baseline to 14 days

Population: Healthy adults with normal appearing big toenails applied toenail polish to both big toes. Jublia was applied to one big toe daily on top of the nail polish. Serial photography and participant report demonstrated the day until the nail polish degraded (became damaged). Control results were not analyzed.

ArmMeasureValue (MEDIAN)Dispersion
Nail Polish and Efinaconazole SolutionObserve Stability of Nail Polish as Evidenced by Serial Photography With Efinaconazole Application in Terms of Days1.5 days of stabilityStandard Deviation 0.5
Efinaconazole Solution, Nail Polish, and Top CoatObserve Stability of Nail Polish as Evidenced by Serial Photography With Efinaconazole Application in Terms of Days5 days of stabilityStandard Deviation 2
Placebo Comparator: Nail Polish OnlyObserve Stability of Nail Polish as Evidenced by Serial Photography With Efinaconazole Application in Terms of Days15 days of stabilityStandard Deviation 0
Base Coat + Nail Polish + Top Coat + Efinaconazole SolutionObserve Stability of Nail Polish as Evidenced by Serial Photography With Efinaconazole Application in Terms of Days5 days of stabilityStandard Deviation 2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026